MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$114,440K
Net Income
-$18,081K
Net Profit Margin
-15.80%
EPS
-$0.6
Unit: Thousand (K) dollars
Revenue Breakdown
Diagnostic Test Third Party Insu...
Diagnostic Test Institutional Cu...
Product And Service Other
Diagnostic Test Self Pay
Revenue Breakdown
Gross profit
Adjusted cost of services
Depreciation and amortization
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
114,440
102,254
120,989
116,743
Cost of services
36,202
34,043
36,721
32,216
Gross profit
78,238
68,211
84,268
84,527
Research and development
19,656
19,804
24,541
19,829
Selling and marketing
-
-
27,131
23,510
General and administrative
-
-
46,831
44,439
Selling, general and administrative
76,037
74,591
-
-
Impairment loss
0
31,287
0*
-
Other operating expenses, net
-
-
0*
-
(loss) income from operations
-17,455
-57,471
-14,235
-3,251
Change in fair value of financial liabilities
220
2,540
1,116
-3,401
Interest expense, net
-1,185
-717
-520
-562
Loss on extinguishment of debt
0
-6,565
-
-
Other income (expense), net
162
-206
-4,591
-174
Total non-operating (expense) income, net
-803
-4,948
-3,995
-4,137
(loss) income before income taxes
-18,258
-62,419
-18,230
-7,388
Income tax benefit (expense)
-518
897
-564
247
Net (loss) income
-17,740
-63,316
-17,666
-7,635
Unrealized gain related to available for sale securities, net
-341
-253
-66
190
Comprehensive (loss) income
-18,081
-63,569
-17,732
-7,445
Basic EPS
-0.6
-2.16
-0.611
-0.27
Diluted EPS
-0.6
-2.16
-0.636
-0.27
Basic Average Shares
29,710,139
29,335,126
29,041,554
28,797,730
Diluted Average Shares
29,710,139
29,335,126
27,867,325
28,797,730
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Comprehensive (loss) income
-$18,081K
(-268.73%↓ Y/Y)
Diagnostic Test Third Party
Insurance
$94,726K
Diagnostic Test
Institutional Customers
$16,118K
Diagnostic Test Self Pay
$1,042K
Net (loss) income
-$17,740K
(-264.12%↓ Y/Y)
Unrealized gain related to
available for sale...
-$341K
(-266.67%↓ Y/Y)
Income tax benefit
(expense)
-$518K
(-110.57%↓ Y/Y)
Diagnostic Test
$111,886K
Product And Service
Other
$2,554K
(loss) income before
income taxes
-$18,258K
(-272.85%↓ Y/Y)
Total revenue
$114,440K
(11.44%↑ Y/Y)
(loss) income from
operations
-$17,455K
(-294.81%↓ Y/Y)
Total non-operating
(expense) income, net
-$803K
(-150.09%↓ Y/Y)
Gross profit
$78,238K
(10.35%↑ Y/Y)
Change in fair value of
financial liabilities
$220K
(-89.91%↓ Y/Y)
Other income
(expense), net
$162K
(-32.22%↓ Y/Y)
Cost of services
$36,202K
(13.88%↑ Y/Y)
Selling, general and
administrative
$76,037K
Interest expense, net
-$1,185K
(-45.04%↓ Y/Y)
Research and development
$19,656K
(30.35%↑ Y/Y)
Buy us a coffee
GeneDx Holdings Corp. (WGS)
GeneDx Holdings Corp. (WGS)